ClinicalTrials.Veeva

Menu

Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

W

Waldemar Link (LINK)

Status

Enrolling

Conditions

Osteoarthritis, Hip
Hip Osteoarthritis
Prosthesis Failure
Prosthesis Survival

Treatments

Device: MobileLink

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.

The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.

Enrollment

520 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
  • Age ≥ 18 years
  • Fully signed patient informed cons

Exclusion criteria

  • Revisions
  • Body Mass Index (BMI) ≥ 40 kg/m²
  • Patient who is foreseeable not able to understand the study and the study-related circumstances
  • Patients who is foreseeable non-compliant to the treatment and the follow-ups
  • Pregnant or breast-feeding women
  • Prisoner

Trial contacts and locations

2

Loading...

Central trial contact

Lisa Skottke, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems